Literature DB >> 28527209

Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction.

Chris Moran1,2,3,4, Richard Beare1,3,4, Thanh Phan3,4, Sergio Starkstein5,6, David Bruce5,6, Mizrahi Romina7, Velandai Srikanth1,3,4.   

Abstract

Diabetes mellitus is associated with an elevated risk of cognitive impairment and dementia. Cerebrovascular disease and neurodegeneration are two major pathways that may explain the effect of diabetes on the brain and therefore deserve investigation. Neuroimaging provides an effective way to investigate the contribution of these pathways in vivo, guiding further mechanistic research and providing biomarkers for clinical correlation or interventional studies. In this paper, we present a narrative review of the state of play with neuroimaging evidence in studies of people with diabetes mellitus, how these data are useful in understanding mechanistic links between diabetes and brain impairment, and possible ways that the field may develop in the future.

Entities:  

Keywords:  Alzheimer’s disease; dementia; diabetes; neuroimaging

Mesh:

Year:  2017        PMID: 28527209     DOI: 10.3233/JAD-161166

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

1.  The effect of diabetes on prefrontal cortex activation patterns during active walking in older adults.

Authors:  Roee Holtzer; Claudene J George; Meltem Izzetoglu; Cuiling Wang
Journal:  Brain Cogn       Date:  2018-05-25       Impact factor: 2.310

2.  Type 2 diabetes mellitus, brain atrophy, and cognitive decline.

Authors:  Chris Moran; Richard Beare; Wei Wang; Michele Callisaya; Velandai Srikanth
Journal:  Neurology       Date:  2019-01-23       Impact factor: 9.910

Review 3.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

4.  Altered Brain Dynamics in Patients With Type 1 Diabetes During Working Memory Processing.

Authors:  Christine M Embury; Alex I Wiesman; Amy L Proskovec; Elizabeth Heinrichs-Graham; Timothy J McDermott; Grace H Lord; Kaitlin L Brau; Andjela T Drincic; Cyrus V Desouza; Tony W Wilson
Journal:  Diabetes       Date:  2018-03-12       Impact factor: 9.461

5.  Hippocampal subfields atrophy contribute more to cognitive impairment in middle-aged patients with type 2 diabetes rather than microvascular lesions.

Authors:  Wen Zhang; Cailiang Gao; Zhao Qing; Zhou Zhang; Yan Bi; Wenbing Zeng; Bing Zhang
Journal:  Acta Diabetol       Date:  2021-03-22       Impact factor: 4.280

6.  Differential impact of glycemic control and comorbid conditions on the neurophysiology underlying task switching in older adults with type 2 diabetes.

Authors:  Christine M Embury; Grace H Lord; Andjela T Drincic; Cyrus V Desouza; Tony W Wilson
Journal:  Aging (Albany NY)       Date:  2022-06-17       Impact factor: 5.955

7.  Altered motor dynamics in type 1 diabetes modulate behavioral performance.

Authors:  Christine M Embury; Elizabeth Heinrichs-Graham; Grace H Lord; Andjela T Drincic; Cyrus V Desouza; Tony W Wilson
Journal:  Neuroimage Clin       Date:  2019-08-07       Impact factor: 4.881

8.  Depression as a Risk Factor for Dementia and Alzheimer's Disease.

Authors:  Vanesa Cantón-Habas; Manuel Rich-Ruiz; Manuel Romero-Saldaña; Maria Del Pilar Carrera-González
Journal:  Biomedicines       Date:  2020-10-28

9.  Increase in Number of Depression Symptoms Over Time is Related to Worse Cognitive Outcomes in Older Adults With Type 2 Diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; Hung-Mo Lin; Xiaoyu Liu; Yuval Berman; Jonathan Schwartz; Laili Soleimani; Mary Sano; Michal Schnaider Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2020-10-07       Impact factor: 4.105

10.  Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.

Authors:  Michael D Abramoff; Patrice E Fort; Ian C Han; K Thiran Jayasundera; Elliott H Sohn; Thomas W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.